首頁 > 市場調查報告書 > 醫療設備

動物模型市場規模、佔有率和成長分析（按動物類型、技術、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1896108

動物模型市場規模、佔有率和成長分析（按動物類型、技術、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

Animal Model Market Size, Share, and Growth Analysis, By Animal Type (Mice, Rat), By Technology (CRISPR, Microinjection), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球動物模型市場規模預計在 2024 年達到 30.3 億美元，從 2025 年的 32.8 億美元成長到 2033 年的 61.1 億美元，在預測期（2026-2033 年）內複合年成長率為 8.1%。

全球動物模型市場是研究人員的重要資源，提供他們能夠精確模擬人類生理和病理的模型。慢性疾病（包括癌症、心血管疾病和神經系統疾病）發生率的上升是推動市場擴張的關鍵因素。特別是，基因改造動物（例如基因轉殖小鼠）技術的進步，使得研究人員能夠更深入地探索特定基因與疾病進展之間的關係。此外，對個人化醫療的日益重視也推動了對患者來源動物模型的需求，從而促進了個人化治療方案的發展。儘管面臨倫理困境和新替代方案的出現等挑戰，動物模型市場在疾病認知和藥物研發中仍然發揮著至關重要的作用。模型開發的持續進步進一步凸顯了這個充滿活力的領域的成長機會。

全球動物模型市場促進因素

全球動物模型市場主要受基因組學和精準醫學進展的驅動，這凸顯了對能夠真實反映個別患者特徵及其對各種治療反應的動物模型的需求。研究人員和製藥公司越來越依賴這些模型來研究特定的基因突變並開發標靶治療方法。患者來源的異種移植（PDX）模型的出現已成為該領域的關鍵方法，該模型將患者的腫瘤樣本移植到動物體內進行藥物測試。這些模型能夠評估針對每位患者量身定做的治療效果，推動了個人化醫療領域對動物模型的需求。

限制全球動物模型市場的因素

儘管動物模型領域取得了顯著進展，但倫理問題和動物福利問題仍然是重大挑戰。動物實驗引發了重要的倫理爭議，並激起了關於動物人道待遇的辯論。公眾日益成長的關注以及嚴格的動物福利法規，使得動物模型的使用受到更多檢驗，尤其是在那些已製定完善動物福利立法的地區。這些倫理考量和法規結構阻礙了動物模型市場的發展，並迫切需要開發既能保持科學嚴謹性又能取代傳統方法的替代技術和模型。

全球動物模型市場趨勢

全球動物模型市場正經歷著向人源化和轉化模型的顯著轉變，這主要受人們對更貼近人類生理和疾病機制的需求所驅動。研究人員致力於開發整合人類細胞、組織和基因修飾的動物模型，以更精確地模擬人類病理。這種轉變在人源化小鼠的開發中尤其明顯，使得免疫介導疾病的研究和先進免疫療法的測試更有效率。隨著這一趨勢的持續發展，它反映了更廣泛的目標，即提高動物模型在藥物研發和疾病研究中的可預測性和適用性，最終實現更有效的治療方法。

查爾斯河實驗室（美國）
傑克森實驗室（美國）
Janvier Labs（法國）
Genoway（法國）
Ozgene（澳洲）
Hera Biolabs（英國）
Crown Bioscience（美國）
Inotiv（美國）
基因改造（日本）
JSR生命科學（日本）
百奧賽汀（中國）
哈伯生物醫學（中國）
賽業生物科技（中國）
Horizon Discovery（英國）
Cellectis（法國）
CRISPR Therapeutics（瑞士）
Editas Medicine（美國）
Intellia Therapeutics（美國）

結論與建議

簡介目錄

Product Code: SQMIG35A2418

Global Animal Model Market size was valued at USD 3.03 Billion in 2024 and is poised to grow from USD 3.28 Billion in 2025 to USD 6.11 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global animal model market serves as a vital resource for researchers, offering models that accurately replicate human physiology and pathology. Key drivers for market expansion include the rising incidence of chronic diseases such as cancer, cardiovascular issues, and neurological disorders. Notably, advancements in genetically modified animals, like transgenic mice, are enabling in-depth exploration of specific genes and their association with disease progression. Furthermore, the growing emphasis on personalized medicine creates demand for patient-derived animal models that enhance tailored therapeutic approaches. Despite challenges like ethical dilemmas and emerging alternatives, the animal model market remains instrumental in disease understanding and drug innovation. Continuous advancements in model development further underscore opportunities for growth within this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Model Market Segments Analysis

Global Animal Model Market is segmented by Animal Type, Technology, Application, End User and region. Based on Animal Type, the market is segmented into Mice, Rat, Guinea Pigs, Rabbits, Hamsters and Others. Based on Technology, the market is segmented into CRISPR, Microinjection and Embryonic Stem Cell Injection. Based on Application, the market is segmented into Research and Development, Production and Quality Control. Based on End User, the market is segmented into Research Institutes, Educational Institutes, Pharmaceutical Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Model Market

The global animal model market is significantly driven by advancements in genomics and precision medicine, highlighting the necessity for animal models that closely reflect individual patient characteristics and their responses to various treatments. Researchers and pharmaceutical companies are increasingly relying on these models to investigate specific genetic variations and to create targeted therapeutic approaches. The emergence of patient-derived xenograft (PDX) models, which involve implanting patient tumor samples into animals for drug testing, has become a prominent avenue in this field. These models enable the evaluation of treatment efficacy tailored to individual patients, thereby propelling the demand for animal models in the realm of personalized medicine.

Restraints in the Global Animal Model Market

Despite notable progress in the field of animal models, ethical concerns and animal welfare issues continue to pose significant challenges. The employment of animals in research raises critical ethical questions and ignites discussions surrounding their humane treatment. Increasing public scrutiny, coupled with stringent animal welfare regulations, has intensified the examination of animal model usage, particularly in regions with robust welfare legislation. These ethical considerations and regulatory frameworks hinder the growth of the animal model market and spur the urgent need for alternative technologies and models that can replace traditional practices while maintaining scientific integrity.

Market Trends of the Global Animal Model Market

The Global Animal Model market is witnessing a notable trend toward humanized and translational models, driven by the demand for greater relevance to human physiology and disease mechanisms. Researchers are increasingly focusing on creating animal models that incorporate human cells, tissues, and genetic modifications to enhance their accuracy in mimicking human conditions. This shift is particularly evident in the development of humanized mice, which allows for more effective studies of immune-related diseases and the testing of advanced immunotherapies. As this trend continues, it reflects the broader goal of improving the predictability and applicability of animal models in drug development and disease research, ultimately leading to more effective therapeutic solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Animal Model Market Size by Animal Type & CAGR (2026-2033)

Market Overview
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others

Global Animal Model Market Size by Technology & CAGR (2026-2033)

Market Overview
CRISPR
Microinjection
Embryonic Stem Cell Injection

Global Animal Model Market Size by Application & CAGR (2026-2033)

Market Overview
Research and Development
Production
Quality Control

Global Animal Model Market Size by End User & CAGR (2026-2033)

Market Overview
Research Institutes
Educational Institutes
Pharmaceutical Companies
Contract Research Organizations

Global Animal Model Market Size & CAGR (2026-2033)

North America (Animal Type, Technology, Application, End User)
- US
- Canada
Europe (Animal Type, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Animal Type, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Animal Type, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Animal Type, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Charles River Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Jackson Laboratory (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Janvier Labs (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genoway (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ozgene (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hera Biolabs (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crown Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inotiv (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transgenic (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JSR Life Sciences (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocytogen (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Harbour BioMed (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyagen Biosciences (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horizon Discovery (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellectis (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CRISPR Therapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Editas Medicine (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intellia Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments